Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 118201-38-0
2. Tetryzolin Nitrate
3. Tetryzoline Nitrate
4. Tetrahydrozoline Nitrate [jan]
5. (+/-)-tetrahydrozoline Nitrate
6. 4,5-dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-1h-imidazole Mononitrate
7. Tetrahydrozoline Nitrate (jan)
8. Tetrahydrozoline (nitrate)
9. 8p9x484t3f
10. 2-(1,2,3,4-tetrahydronaphthalen-1-yl)-4,5-dihydro-1h-imidazole Nitrate
11. Nitric Acid;2-(1,2,3,4-tetrahydronaphthalen-1-yl)-4,5-dihydro-1h-imidazole
12. 1h-imidazole, 4,5-dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-, Mononitrate
13. 1h-imidazole, 4,5-dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-, Nitrate (1:1)
14. Narbel
15. Unii-8p9x484t3f
16. Narbel (tn)
17. Schembl1512892
18. Chebi:145570
19. Tetryzoline Nitrate [who-dd]
20. Akos015895925
21. D00756
22. Q27270852
| Molecular Weight | 263.29 g/mol |
|---|---|
| Molecular Formula | C13H17N3O3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 1 |
| Exact Mass | 263.12699141 g/mol |
| Monoisotopic Mass | 263.12699141 g/mol |
| Topological Polar Surface Area | 90.4 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 284 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Tetrahydrozoline nitrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tetrahydrozoline nitrate, including repackagers and relabelers. The FDA regulates Tetrahydrozoline nitrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tetrahydrozoline nitrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tetrahydrozoline nitrate supplier is an individual or a company that provides Tetrahydrozoline nitrate active pharmaceutical ingredient (API) or Tetrahydrozoline nitrate finished formulations upon request. The Tetrahydrozoline nitrate suppliers may include Tetrahydrozoline nitrate API manufacturers, exporters, distributors and traders.
click here to find a list of Tetrahydrozoline nitrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Tetrahydrozoline nitrate Drug Master File in Japan (Tetrahydrozoline nitrate JDMF) empowers Tetrahydrozoline nitrate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Tetrahydrozoline nitrate JDMF during the approval evaluation for pharmaceutical products. At the time of Tetrahydrozoline nitrate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Tetrahydrozoline nitrate suppliers with JDMF on PharmaCompass.
Tetrahydrozoline nitrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tetrahydrozoline nitrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tetrahydrozoline nitrate GMP manufacturer or Tetrahydrozoline nitrate GMP API supplier for your needs.
A Tetrahydrozoline nitrate CoA (Certificate of Analysis) is a formal document that attests to Tetrahydrozoline nitrate's compliance with Tetrahydrozoline nitrate specifications and serves as a tool for batch-level quality control.
Tetrahydrozoline nitrate CoA mostly includes findings from lab analyses of a specific batch. For each Tetrahydrozoline nitrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tetrahydrozoline nitrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Tetrahydrozoline nitrate EP), Tetrahydrozoline nitrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tetrahydrozoline nitrate USP).
LOOKING FOR A SUPPLIER?
